Diabetic Cardiomyopathy and the Role of Mitochondrial Dysfunction: Novel Insights, Mechanisms, and Therapeutic Strategies

被引:18
|
作者
Aon, Miguel A. [1 ]
Foster, D. Brian [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21205 USA
关键词
D O I
10.1089/ars.2015.6349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This Forum addresses the role of mitochondrial dysfunction in the multifactorial nature of diabetic cardiomyopathy (DCM) from multiple angles. Contributors deliver a diverse and in-depth view of the state-of-the-art in DCM, from bench to bedside. What emerges is a picture of mitochondrial dysfunction as a central upstream defect, inflicted on the heart by diabetes. Collectively, the authors pinpoint high-value knowledge gaps, propose new conceptual frameworks, and highlight understudied, but promising, research themes. Antioxid. Redox Signal. 22, 1499-1501.
引用
收藏
页码:1499 / 1501
页数:3
相关论文
共 50 条
  • [41] New insights into the role of melatonin in diabetic cardiomyopathy
    Huang, Keming
    Luo, Xianling
    Zhong, Yi
    Deng, Li
    Feng, Jian
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):
  • [42] Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms
    Wang, Jing
    Xue, Haojie
    He, Jinyu
    Deng, Li
    Tian, Julong
    Jiang, Yang
    Feng, Jian
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [43] Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets
    Safi, Sher Zaman
    Qvist, Rajes
    Kumar, Selva
    Batumalaie, Kalaivani
    Bin Ismail, Ikram Shah
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [44] Molecular mechanisms of Diabetic Retinopathy, general preventive strategies and novel therapeutic targets
    Safi, S. Z.
    Qvist, R.
    Kumar, S.
    Ismail, I. S. B.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (03)
  • [45] Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies
    Liu, Liping
    Wu, Qin
    Chen, Yuping
    Ren, Huiling
    Zhang, Qi
    Yang, Hengyue
    Zhang, Wenying
    Ding, Tingyu
    Wang, Shujie
    Zhang, Yan
    Liu, Yun
    Sun, Jihu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [46] Increased susceptibility of mitochondrial subpopulations to diabetic cardiomyopathy associated dysfunction
    Dabkowski, Erinne R.
    Williamson, Courtney L.
    Hollander, John M.
    FASEB JOURNAL, 2007, 21 (06): : A819 - A819
  • [47] Therapeutic Role of Caveolin-3 in Mitochondrial Directed Cardioprotection during the Development of Diabetic Cardiomyopathy
    Migita, Michael Yoshimichi
    Zemljic-Harpf, Alice E.
    Finley, J. Cameron
    Kellerhals, Sarah E.
    Fridolfsson, Heidi N.
    Panneerselvam, Mathivadhani
    Niesman, Ingrid R.
    Ali, Sameh S.
    Roth, David M.
    Patel, Hemal H.
    FASEB JOURNAL, 2013, 27
  • [48] Novel insights into the central protective role of ACE2 in diabetic cardiomyopathy: from underlying signaling pathways to therapeutic perspectives
    Li, Xinyi
    Qu, Shunlin
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025,
  • [49] Mitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities
    Zhang, Ping Na
    Zhou, Meng Qi
    Guo, Jing
    Zheng, Hui Juan
    Tang, Jingyi
    Zhang, Chao
    Liu, Yu Ning
    Liu, Wei Jing
    Wang, Yao Xian
    JOURNAL OF DIABETES RESEARCH, 2021, 2021
  • [50] Role of novel biomarkers in diabetic cardiomyopathy
    Kumric, Marko
    Ticinovic Kurir, Tina
    Borovac, Josip A.
    Bozic, Josko
    WORLD JOURNAL OF DIABETES, 2021, 12 (06)